TLR4 and hepatocellular carcinoma: NE can enter tumor cells and degrade tumor suppressors or remodel the extracellular matrix, while HMGB1 (a damage-associated molecular pattern) engages receptors like RAGE/TLR4 on hepatoma cells to activate NF-κB signaling, activating a pro-survival, pro-proliferation program [58,59].